Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O4RX
|
|||
Drug Name |
US10179791, Compound 176
|
|||
Synonyms |
SCHEMBL327072; BDBM321322; US10179791, Compound 176
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H23Cl2NO3
|
|||
Canonical SMILES |
C1CN(CCC12COC3=C2C=CC(=C3)C4CC4C5=C(C=CC=C5Cl)Cl)CC(=O)O
|
|||
InChI |
1S/C23H23Cl2NO3/c24-18-2-1-3-19(25)22(18)16-11-15(16)14-4-5-17-20(10-14)29-13-23(17)6-8-26(9-7-23)12-21(27)28/h1-5,10,15-16H,6-9,11-13H2,(H,27,28)
|
|||
InChIKey |
UTYPIEPGWJMTNG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target Info | Inhibitor | [1] |
Target's Patent Info | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target's Patent Info | [1] | |
KEGG Pathway | Sphingolipid signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | S1P3 pathway | |||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Spiro-cyclic amine derivatives as S1P modulators. US10179791. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.